{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:52:30Z","timestamp":1789055550201,"version":"build-2803163510"},"reference-count":54,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["1885\/1-2"],"award-info":[{"award-number":["1885\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["NA 1398\/1-1"],"award-info":[{"award-number":["NA 1398\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FAUN Stiftung","award":["-"],"award-info":[{"award-number":["-"]}]},{"name":"ERARE17-114","award":["NE 2118\/2-1"],"award-info":[{"award-number":["NE 2118\/2-1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>X-chromosomal retinitis pigmentosa (RP) frequently is caused by mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene. We evaluated the potential of PTC124 (Ataluren, TranslamaTM) treatment to promote ribosomal read-through of premature termination codons (PTC) in RPGR. Expression constructs in HEK293T cells showed that the efficacy of read-through reagents is higher for UGA than UAA PTCs. We identified the novel hemizygous nonsense mutation c.1154T &gt; A, p.Leu385* (NM_000328.3) causing a UAA PTC in RPGR and generated patient-derived fibroblasts. Immunocytochemistry of serum-starved control fibroblasts showed the RPGR protein in a dot-like expression pattern along the primary cilium. In contrast, RPGR was no longer detectable at the primary cilium in patient-derived cells. Applying PTC124 restored RPGR at the cilium in approximately 8% of patient-derived cells. RT-PCR and Western blot assays verified the pathogenic mechanisms underlying the nonsense variant. Immunofluorescence stainings confirmed the successful PTC124 treatment. Our results showed for the first time that PTC124 induces read-through of PTCs in RPGR and restores the localization of the RPGR protein at the primary cilium in patient-derived cells. These results may provide a promising new treatment option for patients suffering from nonsense mutations in RPGR or other genetic diseases.<\/jats:p>","DOI":"10.3390\/ijms21228418","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T14:10:41Z","timestamp":1605017441000},"page":"8418","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Translational Read-Through Therapy of RPGR Nonsense Mutations"],"prefix":"10.3390","volume":"21","author":[{"given":"Christine","family":"V\u00f6ssing","sequence":"first","affiliation":[{"name":"Human Genetics, Faculty of Medicine and Health Sciences, University of Oldenburg, 26129 Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6667-4452","authenticated-orcid":false,"given":"Marta","family":"Owczarek-Lipska","sequence":"additional","affiliation":[{"name":"Human Genetics, Faculty of Medicine and Health Sciences, University of Oldenburg, 26129 Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Nagel-Wolfrum","sequence":"additional","affiliation":[{"name":"Institute of Developmental Biology and Neurobiology, Johannes Gutenberg-University of Mainz, 55099 Mainz, Germany"},{"name":"Institute of Molecular Physiology, Johannes Gutenberg-University of Mainz, 55099 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Reiff","sequence":"additional","affiliation":[{"name":"Eye Center, Albert-Ludwigs-University of Freiburg, 79106 Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"J\u00fcschke","sequence":"additional","affiliation":[{"name":"Human Genetics, Faculty of Medicine and Health Sciences, University of Oldenburg, 26129 Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Neidhardt","sequence":"additional","affiliation":[{"name":"Human Genetics, Faculty of Medicine and Health Sciences, University of Oldenburg, 26129 Oldenburg, Germany"},{"name":"Research Center Neurosensory Science, University of Oldenburg, 26129 Oldenburg, Germany"},{"name":"Joint Research Training Group of the Faculty of Medicine and Health Sciences, University of Oldenburg, Germany and the University Medical Center Groningen, 9700 Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/138920211795860107","article-title":"Retinitis pigmentosa: Genes and disease mechanisms","volume":"12","author":"Ferrari","year":"2011","journal-title":"Curr Genom."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nsmb.1396","article-title":"The retinitis pigmentosa 2 gene product is a GTPase-activating protein for Arf-like 3","volume":"15","author":"Veltel","year":"2008","journal-title":"Nat. Struct Mol. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.preteyeres.2010.03.004","article-title":"The molecular basis of human retinal and vitreoretinal diseases","volume":"29","author":"Berger","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archopht.1988.01060130395029","article-title":"X-linked retinitis pigmentosa. Profile of clinical findings","volume":"106","author":"Fishman","year":"1988","journal-title":"Arch. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"8232","DOI":"10.1167\/iovs.12-11025","article-title":"Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease","volume":"53","author":"Branham","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/379379","article-title":"RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa","volume":"73","author":"Sharon","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1167\/iovs.02-0605","article-title":"X-linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15","volume":"44","author":"Bader","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1167\/iovs.09-4031","article-title":"Mutation- and tissue-specific alterations of RPGR transcripts","volume":"51","author":"Schmid","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/humu.20521","article-title":"Identification and characterization of a novel RPGR isoform in human retina","volume":"28","author":"Neidhardt","year":"2007","journal-title":"Hum. Mutat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/hmg\/9.14.2095","article-title":"The retinitis pigmentosa GTPase regulator (RPGR) interacts with novel transport-like proteins in the outer segments of rod photoreceptors","volume":"9","author":"Roepman","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/hmg\/8.8.1571","article-title":"RPGR transcription studies in mouse and human tissues reveal a retina-specific isoform that is disrupted in a patient with X-linked retinitis pigmentosa","volume":"8","author":"Kirschner","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/gt.2014.128","article-title":"Localizing the RPGR protein along the cilium: A new method to determine efficacies to treat RPGR mutations","volume":"22","author":"Glaus","year":"2015","journal-title":"Gene Ther"},{"key":"ref_13","first-page":"3373","article-title":"Complex expression pattern of RPGR reveals a role for purine-rich exonic splicing enhancers","volume":"43","author":"Hong","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1167\/iovs.02-1206","article-title":"RPGR isoforms in photoreceptor connecting cilia and the transitional zone of motile cilia","volume":"44","author":"Hong","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/hmg\/11.16.1899","article-title":"Species-specific subcellular localization of RPGR and RPGRIP isoforms: Implications for the phenotypic variability of congenital retinopathies among species","volume":"11","author":"Mavlyutov","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ng0596-35","article-title":"A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3)","volume":"13","author":"Meindl","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1107\/S0907444998007768","article-title":"Crystallization and preliminary X-ray analysis of human RCC1, the regulator of chromosome condensation","volume":"55","author":"Renault","year":"1999","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/humu.20733","article-title":"The human retinitis pigmentosa GTPase regulator gene variant database","volume":"29","author":"Shu","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/78182","article-title":"Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa","volume":"25","author":"Vervoort","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.visres.2007.08.005","article-title":"Retinitis Pigmentosa GTPase Regulator (RPGR) protein isoforms in mammalian retina: Insights into X-linked Retinitis Pigmentosa and associated ciliopathies","volume":"48","author":"He","year":"2008","journal-title":"Vision Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tig.2016.04.007","article-title":"The Meaning of NMD: Translate or Perish","volume":"32","author":"Brogna","year":"2016","journal-title":"Trends Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BJ20100699","article-title":"NMD: RNA biology meets human genetic medicine","volume":"430","author":"Bhuvanagiri","year":"2010","journal-title":"Biochem. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s10020-018-0024-7","article-title":"Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons","volume":"24","author":"Dabrowski","year":"2018","journal-title":"Mol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2174\/1381612823666161122142950","article-title":"Therapeutic Suppression of Nonsense Mutation: An Emerging Target in Multiple Diseases and Thrombotic Disorders","volume":"23","author":"Alam","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40259-016-0157-6","article-title":"Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs)","volume":"30","author":"Moller","year":"2016","journal-title":"BioDrugs"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1073\/pnas.1118847109","article-title":"Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa","volume":"109","author":"Beltran","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1167\/iovs.04-1065","article-title":"A single, abbreviated RPGR-ORF15 variant reconstitutes RPGR function in vivo","volume":"46","author":"Hong","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2017.05.001","article-title":"Cilia\u2014The sensory antennae in the eye","volume":"60","author":"Wolfrum","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Morais, P., Adachi, H., and Yu, Y.T. (2020). Suppression of Nonsense Mutations by New Emerging Technologies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124394"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: A randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19969","DOI":"10.1038\/srep19969","article-title":"Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells","volume":"6","author":"Bassuk","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.cub.2015.07.029","article-title":"Restoration of Vision with Ectopic Expression of Human Rod Opsin","volume":"25","author":"Eleftheriou","year":"2015","journal-title":"Curr. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"ref_34","first-page":"15","article-title":"Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results","volume":"22","author":"Politano","year":"2003","journal-title":"Acta Myol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/1756285610388693","article-title":"Aminoglycoside-induced mutation suppression (stop codon readthrough) as a therapeutic strategy for Duchenne muscular dystrophy","volume":"3","author":"Malik","year":"2010","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00109-002-0363-1","article-title":"Aminoglycoside suppression of a premature stop mutation in a Cftr-\/- mouse carrying a human CFTR-G542X transgene","volume":"80","author":"Du","year":"2002","journal-title":"J. Mol. Med. (Berl)"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI7866","article-title":"Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice","volume":"104","author":"Cordier","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","article-title":"Introducing sense into nonsense in treatments of human genetic diseases","volume":"24","author":"Linde","year":"2008","journal-title":"Trends Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.clinbiochem.2012.05.034","article-title":"Cystic fibrosis: Insight into CFTR pathophysiology and pharmacotherapy","volume":"45","author":"Lubamba","year":"2012","journal-title":"Clin. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/emmm.201201438","article-title":"A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation","volume":"4","author":"Goldmann","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.1167\/iovs.10-5741","article-title":"Beneficial read-through of a USH1C nonsense mutation by designed aminoglycoside NB30 in the retina","volume":"51","author":"Goldmann","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41598-017-00142-7","article-title":"Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs","volume":"7","author":"Ramsden","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/hmg\/ddu509","article-title":"Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells","volume":"24","author":"Schwarz","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.exer.2008.05.016","article-title":"Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa","volume":"87","author":"Guerin","year":"2008","journal-title":"Exp. Eye Res."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Samanta, A., Stingl, K., Kohl, S., Ries, J., Linnert, J., and Nagel-Wolfrum, K. (2019). Ataluren for the Treatment of Usher Syndrome 2A Caused by Nonsense Mutations. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246274"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1073\/pnas.1817639116","article-title":"Disruption of RPGR protein interaction network is the common feature of RPGR missense variations that cause XLRP","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","first-page":"4533","article-title":"Prenylated retinal ciliopathy protein RPGR interacts with PDE6delta and regulates ciliary localization of Joubert syndrome-associated protein INPP5E","volume":"25","author":"Rao","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1073\/pnas.1424127112","article-title":"Nonsense suppression by near-cognate tRNAs employs alternative base pairing at codon positions 1 and 3","volume":"112","author":"Roy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exer.2017.01.001","article-title":"Mechanism and evidence of nonsense suppression therapy for genetic eye disorders","volume":"155","author":"Richardson","year":"2017","journal-title":"Exp. Eye Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jmg.39.1.62","article-title":"In vitro analysis of aminoglycoside therapy for the Arg120stop nonsense mutation in RP2 patients","volume":"39","author":"Grayson","year":"2002","journal-title":"J. Med. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"El Shamieh, S., Mejecase, C., Bertelli, M., Terray, A., Michiels, C., Condroyer, C., Fouquet, S., Sadoun, M., Clerin, E., and Liu, B. (2017). Further Insights into the Ciliary Gene and Protein KIZ and Its Murine Ortholog PLK1S1 Mutated in Rod-Cone Dystrophy. Genes (Basel), 8.","DOI":"10.3390\/genes8100277"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/0883073810371129","article-title":"Read-through strategies for suppression of nonsense mutations in Duchenne\/Becker muscular dystrophy: Aminoglycosides and ataluren (PTC124)","volume":"25","author":"Finkel","year":"2010","journal-title":"J. Child. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1007\/s11033-019-04906-4","article-title":"Novel mutations in the GJC2 gene associated with Pelizaeus-Merzbacher-like disease","volume":"46","author":"Mulahasanovic","year":"2019","journal-title":"Mol. Biol. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/22\/8418\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:31:23Z","timestamp":1760178683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/22\/8418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":54,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["ijms21228418"],"URL":"https:\/\/doi.org\/10.3390\/ijms21228418","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]}}}